Bezafibrate, Pan-PPAR agonist

Be the first to review this product! Submit a review

|

(0 Publication)

MW 361.8 Da, Purity >99%. Pan-PPAR agonist (EC₅₀ values are 50, 60 and 20 μM at PPARα, PPARγ and PPARδ human receptors respectively). More efficient than fenofibrate (ab120832) in reducing body weight and blood glucose. Antidiabetic and antihyperlipidemic effects.

View Alternative Names

FAAR, FABP 1, FABP 2, FABPI_HUMAN, FABPL_HUMAN, Fatty acid binding protein 1 liver, Fatty acid binding protein 2 intestinal, Fatty acid binding protein intestinal, Fatty acid-binding protein, Fatty acid-binding protein 1, Fatty acid-binding protein 2, Fatty acid-binding protein liver, I-FABP, Intestinal fatty acid binding protein 2, Intestinal-type fatty acid-binding protein, L-FABP, Liver-type fatty acid-binding protein, MGC133132, MGC2237, MGC2452, MGC3931, NR1C1, NR1C2, NR1C3, NUC1, NUCI, NUCII, Nuclear hormone receptor 1, Nuclear receptor subfamily 1 group C member 1, Nuclear receptor subfamily 1 group C member 2, Nuclear receptor subfamily 1 group C member 3, OTTHUMP00000163925, OTTHUMP00000197740, OTTHUMP00000197741, PPAR, PPAR-alpha, PPAR-beta, PPAR-delta, PPAR-gamma, PPAR-鑴, PPARA_HUMAN, PPARB, PPARD_HUMAN, PPARG2, PPARG_HUMAN, Peroxisome proliferative activated receptor alpha, Peroxisome proliferative activated receptor delta, Peroxisome proliferator activated receptor gamma 2, Peroxisome proliferator-activated receptor alpha, Peroxisome proliferator-activated receptor beta, Peroxisome proliferator-activated receptor beta (PPAR-beta), Peroxisome proliferator-activated receptor delta, Peroxisome proliferator-activated receptor gamma, hPPAR, intestinal, intestinal FABP